- Products & Services
- Knowledge Base
LOS ANGELES, CA, January 21, 2010 /24-7PressRelease/ -- (Phentolamine Mesylate) Injection Novalar is pleased to provide you with this guide to educating your patients about OraVerse.
OraVerse, as the first and only product to safely and effectively reverse local anesthesia, OraVerse gives you an opportunity to start a whole new conversation about the level of comfort you bring to your patient's dental experience. And it starts with communication.
In this brief guide you'll find content features and images that are ideal for use in practice newsletters, websites, email blasts or letters to patients. We ask that you use this content only in accordance with the guidelines set forth below.
More in-depth information can also be accessed on Novalar's website. We encourage you to provide hyperlinks to www.OraVerse.com, and again follow the guidelines below.
In addition, Patient Education Brochures are available for distribution to your patients. You can request copies through our Customer Care Department at 888.888.1441.
Guidelines for using logo, images or text features
There are a few requirements to keep in mind when using these materials:
• OraVerse is a drug and subject to FDA regulations on promotional materials.
• Because of FDA requirements, if you would like to use any of the text features, you must use the feature in its entirety and it must all appear on the same page of your website, email or other communication medium.
• In particular, the full text of the Important Safety Information must be included in anything you post. It has been included in each of the attached.
• The Important Safety Information statement must appear in the same size and with the same prominence as other text on the page about OraVerse.
• Do not alter or remove the Important Safety Information statement or any other part of the piece.
• OraVerse must always have a capital O and V, as well as the on the first use of the name (except in the web address: www.OraVerse.com).
Important Safety Information
Tachycardia, bradycardia, and cardiac arrhythmias may occur with the use of phentolamine or other alpha-adrenergic blocking agents. Although such effects are uncommon with OraVerse (phentolamine mesylate), clinicians should be alert to the signs and symptoms of these events, particularly in patients with a history of cardiovascular disease. Following parenteral use of phentolamine at doses between 5 to 15 times higher than the recommended dose of OraVerse, myocardial infarction, and cerebrovascular spasm and occlusion have been reported, usually in association with marked hypotensive episodes producing shock-like states.
If you have questions, please contact Lisa Olsen, Product/Marketing Manager at 858.436.1134 or via email at firstname.lastname@example.org
Feature 1: Product-related content for newsletters, websites, letters to patients
Headline: Now It's Possible: Reversing Numbness with OraVerse
Now you can get on with your day after routine dental procedures thanks to a new product that reverses the effects of local anesthesia. This new measure of comfort is for patients who dislike the lingering numbness that can last for 3-5 hours after leaving our office.
To deliver superior care, we're always finding better ways to ensure your comfort and improve your dental experience. OraVerse is the first and only product proven safe and effective in accelerating a return to normal sensation and function after a local anesthetic containing a vasoconstrictor has been used. So now in about half the time, you'll be talking, smiling and drinking just like normal. And OraVerse can benefit nearly any patient, but is not recommended for children under 6 years of age or weighing less than 15 kg (33 lbs).
We want you to have the most comfortable experience possible. It's a commitment that begins when you walk in the door and extends long after you leave. So if you're among the many patients who dislike lingering numbness and its limitations, let's discuss whether OraVerse is the right choice for you during your next dental visit.
About Woodside Dental
Woodside Dental proudly serves Los Angeles, West Los Angeles, Beverly Hills, Santa Monica, Sherman Oaks, Marina Del Ray, Culver City, Brentwood, Westwood, Century City and the surrounding areas. Woodside Dental is devoted to comprehensive and preventive patient care. Dr. Sheba Mahmoodian, Dr. Bina and Dr. Tisa Siadatie all offer years of experience and concern for the physical and emotional comfort of their patients. At Woodside Dental's website, http://www.woodside-dental.com, there is an abundance of information about the procedures offered, including Zoom teeth whitening, Invisalign clear braces, dental implants, veneers, cosmetic dentistry and more. Woodside Dental encourages its patients to explore and learn all they can about its dental procedures. They believe their patients should have as much information as possible in order to make important, informed decisions regarding their oral health and treatment options.
10921 Wilshire Blvd. #505 (corner of Wilshire Blvd.)
Los Angeles CA 90024
# # #